1.
Gordan H, Beyranvand MR, Sheibani M, Asadpur Piranfar M, Pourhoseingholi MA. Cost Effectiveness of Rivaroxaban versus Warfarin to Prevent Stroke in Iranian AF Patients. Stud. Rese. Transl. Med. [Internet]. 2020 Sep. 14 [cited 2025 Mar. 17];2(3):18-24. Available from: https://journals.sbmu.ac.ir/index.php/srtm/article/view/31619